172
Participants
Start Date
April 3, 2017
Primary Completion Date
December 31, 2018
Study Completion Date
December 31, 2018
AVX012 Ophthalmic Solution Low dose
Ocular topical administration of AVX Ophthalmic Solution Low dose
AVX012 Ophthalmic Solution High dose
Ocular topical administration of AVX Ophthalmic Solution High dose
Placebo (vehicle)
Ocular topical administration of placebo (vehicle Ophthalmic Solution)
NOT_YET_RECRUITING
Clinica Oftalvist Jerez, Jerez de la Frontera
NOT_YET_RECRUITING
clínica Oftalvist Granada, Granada
NOT_YET_RECRUITING
Clínica Universitaria de Navarra_ Madrid, Madrid
NOT_YET_RECRUITING
Clínica Oftalvist Moncloa, Madrid
RECRUITING
H Universitario Ramón y Cajal, Madrid
RECRUITING
H Clínico San Carlos, Madrid
RECRUITING
Hospital General Universitario Reina Sofía, Murcia
RECRUITING
Clínica Universitaria de Navarra, Pamplona
RECRUITING
Instituto Oftalmológico Fernández Vega, Oviedo
NOT_YET_RECRUITING
clinica Oftalvist Valencia, Valencia
NOT_YET_RECRUITING
Hospital Universitario La Fé, Valencia
RECRUITING
Instituto Universitario de Oftalmobiología Aplicada (IOBA), Valladolid
RECRUITING
H Miguel Servet, Zaragoza
RECRUITING
H Universitario Lozano Blesa, Zaragoza
NOT_YET_RECRUITING
Clínica Oftalvist Vistahermosa, Alicante
RECRUITING
Innova Ocular ICO Barcelona, Barcelona
NOT_YET_RECRUITING
Centro de Oftalmologia Barraquer, Barcelona
NOT_YET_RECRUITING
H Vall de Hebron, Barcelona
RECRUITING
H Clinic, Barcelona
RECRUITING
H General de Cataluña, Barcelona
NOT_YET_RECRUITING
H Germas Trias Pujol, Barcelona
Lead Sponsor
Avizorex Pharma, S.L.
INDUSTRY